And the winner is: Regional citrate anticoagulation

Critical Care Medicine

Volumn 37, Issue 2, 2009, Pages 764-765

  Bouman, Catherine S C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute kidney injury; Citrate; Continuous renal replacement therapy; Heparin

Indexed keywords

BICARBONATE; CALCIUM; CALCIUM ION; CITRATE CALCIUM; CITRATE TRISODIUM; CITRIC ACID; ELECTROLYTE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ACID BASE BALANCE; ALKALOSIS; ANTICOAGULATION; BLEEDING; BLOOD CLOTTING; CALCIUM BLOOD LEVEL; CHELATION; CITRIC ACID CYCLE; CLINICAL TRIAL; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DRUG WITHDRAWAL; EDITORIAL; ELECTROLYTE BLOOD LEVEL; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERNATREMIA; INFLAMMATION; INFLAMMATORY CELL; INTENSIVE CARE UNIT; KIDNEY INJURY; METABOLIC ALKALOSIS; METABOLIC DISORDER; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PH; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SURVIVAL; THROMBOCYTOPENIA;

ACUTE KIDNEY INJURY; ANTICOAGULANTS; CITRATES; CLINICAL TRIALS AS TOPIC; HUMANS; RENAL REPLACEMENT THERAPY;

EID: 67650391955     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318194df2e     Document Type: Editorial

References (14)

1. Uchino S, Bellomo R, Morimatsu H, et al: Continuous renal replacement therapy: A worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 2007; 33:1563-1570
2. Egi M, Naka T, Bellomo R, et al: A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration. Int J Artif Organs 2005; 28:1211-1218
3. Tolwani AJ, Prendergast MB, Speer RR, et al: A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 2006; 1:79-87
4. Bohler J, Schollmeyer P, Dressel B, et al: Reduction of granulocyte activation during hemodialysis with regional citrate anticoag-ulation: Dissociation of complement activation and neutropenia from neutrophil de-granulation. J Am Soc Nephrol 1996; 7:234-241
5. Bos JC, Grooteman MP, van Houte AJ, et al: Low polymorphonuclear cell degranulation during citrate anticoagulation: A comparison between citrate and heparin dialysis. Nephrol Dial Transplant 1997; 12:1387-1393
6. Hetzel GR, Taskaya G, Sucker C, et al: Citrate plasma levels in patients under regional an-ticoagulation in continuous venovenous he-mofiltration. Am J Kidney Dis 2006; 48: 806-811
7. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, et al: Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009; 37:545-552
8. Betjes MG, van Oosterom D, van Agteren M, et al: Regional citrate versus heparin antico-agulation during venovenous hemofiltration in patients at low risk for bleeding: Similar hemofilter survival but significantly less bleeding. J Nephrol 2007; 20:602-608
9. Monchi M, Berghmans D, Ledoux D, et al: Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med 2004; 30:260-265
10. Kutsogiannis DJ, Gibney RT, Stollery D, et al: Regional citrate versus systemic heparin an-ticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005; 67:2361-2367
11. Bagshaw SM, Laupland KB, Boiteau PJ, et al: Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 2005; 20: 155-161
12. Mehta RL, McDonald BR, Aguilar MM, et al: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38:976-981
13. Demirjian S, Teo BW, Paganini EP: Alkale-mia during continuous renal replacement therapy and mortality in critically ill patients. Crit Care Med 2008; 36:1513-1517
14. Gabutti L, Ferrari N, Mombelli G, et al: The favorable effect of regional citrate anticoag-ulation on interleukin-1beta release is dissociated from both coagulation and complement activation. J Nephrol 2004; 17: 819-825